EUVIMEDEUVIMED entdecken
Crossref

The role of vorasidenib, a dual inhibitor of the mutant IDH1 and IDH2 enzymes, in the treatment of diffuse adult-type gliomas

Tomasz Kubiatowski, Ewa Iżycka-Świeszewska

Oncology in Clinical Practice · 15.01.2026 · 22

DOI: 10.5603/ocp.110138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology in Clinical Practice, online erschienen am 15.01.2026. Verfasst von Tomasz Kubiatowski und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kubiatowski, T., & Iżycka-Świeszewska, E. (2026). The role of vorasidenib, a dual inhibitor of the mutant IDH1 and IDH2 enzymes, in the treatment of diffuse adult-type gliomas. Oncology in Clinical Practice, 22(0). https://doi.org/10.5603/ocp.110138

Vancouver

Kubiatowski T, Iżycka-Świeszewska E. The role of vorasidenib, a dual inhibitor of the mutant IDH1 and IDH2 enzymes, in the treatment of diffuse adult-type gliomas. Oncology in Clinical Practice. 2026;22(0). doi:10.5603/ocp.110138

BibTeX
@article{Kubiatowski2026,
  author = {Kubiatowski, Tomasz and Iżycka-Świeszewska, Ewa},
  title = {The role of vorasidenib, a dual inhibitor of the mutant IDH1 and IDH2 enzymes, in the treatment of diffuse adult-type gliomas},
  journal = {Oncology in Clinical Practice},
  year = {2026},
  volume = {22},
  number = {0},
  doi = {10.5603/ocp.110138}
}
Kostenlos starten →